These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6874949)

  • 1. Membrane microviscosity is increased in the erythrocytes of patients with adrenoleukodystrophy and adrenomyeloneuropathy.
    Knazek RA; Rizzo WB; Schulman JD; Dave JR
    J Clin Invest; 1983 Jul; 72(1):245-8. PubMed ID: 6874949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenoleukodystrophy: fatty acid analysis of total glycerophospholipids in erythrocyte membranes.
    Antoku Y; Sakai T; Goto I; Katafuchi Y; Sato H; Iwashita H; Kuroiwa Y
    Acta Neurol Scand; 1985 Aug; 72(2):193-7. PubMed ID: 4050328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenoleukodystrophy: increased plasma content of saturated very long chain fatty acids.
    Moser HW; Moser AB; Frayer KK; Chen W; Schulman JD; O'Neill BP; Kishimoto Y
    Neurology; 1981 Oct; 31(10):1241-9. PubMed ID: 7202134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormality of long-chain fatty acids in erythrocyte membrane sphingomyelin from patients with adrenoleukodystrophy.
    Tsuji S; Suzuki M; Ariga T; Sekine M; Kuriyama M; Miyatake T
    J Neurochem; 1981 Mar; 36(3):1046-9. PubMed ID: 7205256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Very long-chain fatty acids in erythrocyte membrane phospholipids in adrenoleukodystrophy.
    Tanaka K; Shimada M; Naruto T; Yamamoto H; Nishizawa K; Saeki Y
    Acta Paediatr Jpn; 1989 Apr; 31(2):136-43. PubMed ID: 2516693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenoleukodystrophy in Israel: a genetic, clinical and biochemical study.
    Chemke J; Lieberman E; Carmi R; Abarbanel Y; Costeff H; Goldhammer Y; Moser HW
    Isr J Med Sci; 1984 Dec; 20(12):1123-32. PubMed ID: 6097565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenoleukodystrophy: dietary oleic acid lowers hexacosanoate levels.
    Rizzo WB; Phillips MW; Dammann AL; Leshner RT; Jennings SS; Avigan J; Proud VK
    Ann Neurol; 1987 Mar; 21(3):232-9. PubMed ID: 3037987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenoleukodystrophy: detection of increased very long chain fatty acids by high-performance liquid chromatography.
    Kobayashi T; Katayama M; Suzuki S; Tomoda H; Goto I; Kuroiwa Y
    J Neurol; 1983; 230(4):209-15. PubMed ID: 6198480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary treatment of adrenoleukodystrophy.
    Suzuki S; Kobayashi T; Goto I; Kuroiwa Y
    Neurology; 1986 Jan; 36(1):104-6. PubMed ID: 3941763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenoleukodystrophy: elevated C26 fatty acid in cultured skin fibroblasts.
    Moser HW; Moser AB; Kawamura N; Murphy J; Suzuki K; Schaumburg H; Kishimoto Y
    Ann Neurol; 1980 Jun; 7(6):542-9. PubMed ID: 7436359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenoleukodystrophy: abnormality of very long-chain fatty acids in erythrocyte membrane phospholipids.
    Antoku Y; Sakai T; Goto I; Iwashita H; Kuroiwa Y
    Neurology; 1984 Nov; 34(11):1499-1501. PubMed ID: 6493501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simple diagnostic method of adrenoleukodystrophy: total fatty acid analysis of erythrocyte membranes.
    Antoku Y; Sakai T; Tsukamoto K; Imanishi K; Ohtsuka Y; Iwashita H; Goto I
    Clin Chim Acta; 1987 Oct; 169(1):121-5. PubMed ID: 3677434
    [No Abstract]   [Full Text] [Related]  

  • 13. Adrenoleukodystrophy without adrenal insufficiency and its magnetic resonance imaging.
    Nishio H; Kodama S; Tsubota T; Takumi T; Takahashi T; Yokoyama S; Matsuo T
    J Neurol; 1985; 232(5):265-70. PubMed ID: 4056832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenoleukodystrophy: VLCFAs in erythrocytes.
    Antoku Y
    Neurology; 1988 May; 38(5):826-7. PubMed ID: 3362386
    [No Abstract]   [Full Text] [Related]  

  • 15. Determination of C20-C30 fatty acids by reversed-phase chromatographic techniques: an efficient method to quantitate minor fatty acids in serum of patients with adrenoleukodystrophy.
    Alberghina M; Fiumara A; Pavone L; Giuffrida AM
    Neurochem Res; 1984 Dec; 9(12):1719-27. PubMed ID: 6531070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of long-chain, saturated fatty acids on membrane microviscosity and adrenocorticotropin responsiveness of human adrenocortical cells in vitro.
    Whitcomb RW; Linehan WM; Knazek RA
    J Clin Invest; 1988 Jan; 81(1):185-8. PubMed ID: 2891726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased synthesis of hexacosanoic acid (C23:0) by cultured skin fibroblasts from patients with adrenoleukodystrophy (ALD) and adrenomyeloneuropathy (AMN).
    Tsuji S; Sano T; Ariga T; Miyatake T
    J Biochem; 1981 Oct; 90(4):1233-6. PubMed ID: 7309718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peroxisomal lignoceroyl-CoA ligase deficiency in childhood adrenoleukodystrophy and adrenomyeloneuropathy.
    Lazo O; Contreras M; Hashmi M; Stanley W; Irazu C; Singh I
    Proc Natl Acad Sci U S A; 1988 Oct; 85(20):7647-51. PubMed ID: 3174658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Capillary gas-liquid chromatographic-mass spectrometric measurement of very long chain (C22 to C26) fatty acids in microliter samples of plasma.
    Aubourg P; Bougnères PF; Rocchiccioli F
    J Lipid Res; 1985 Feb; 26(2):263-7. PubMed ID: 3989386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of [17,18-3H2]hexacosanoic acid and [15,16-3H2]lignoceric acid in cultured skin fibroblasts from patients with adrenoleukodystrophy (ALD) and adrenomyeloneuropathy (AMN).
    Tsuji S; Sano-Kawamura T; Ariga T; Miyatake T
    J Neurol Sci; 1985 Dec; 71(2-3):359-67. PubMed ID: 4087029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.